Oscare Medical signs distribution agreement with Remeda Allemann in Switzerland

Remeda Allemann + Partner GmbH has been providing healthcare technology solutions in Switzerland already since 1991. Remeda’s product portfolio includes Galileo vibration devices for rehabilitation and sports. The devices increase muscle strength, muscular performance and balance. The increase in muscular strength leads to bone growth in the medium term. Remeda also distributes Galileo’s pQCT (peripheral quantitative computed tomography) devices for the measurement of bone properties. The expertise in bone measurements and rehabilitation provides the personnel of Remeda excellent knowhow to start marketing the OsCare Sono® for osteoporosis screening in Switzerland. Remeda also provides surveillance, communication, alarm and GPS systems for hospitals, clinics and elderly homes.

The annual costs of hospitalizations for osteoporotic fractures in Switzerland are greater than those for myocardial infarction, stroke and breast cancer. The direct medical cost of hospitalization of patients with osteoporosis and related fractures was 357 million CHF in year 2000. Between 2000-2020, osteoporotic hip, vertebral and wrist fractures were predicted to rise by 33%, 27% and 19%, respectively.

The OsCare Sono® will enable easy and early detection of reduced bone strength and osteoporosis in clinics, doctor’s offices and pharmacies, helping the caregiver and patient to act early in order to prevent fractures.

For more information, please contact:

Managing Director Urs Allemann
REMEDA GMBH
Brahmsstrasse 18
8003 Zürich
T. +41 (0)44 491 30 27
Fax +41 (0)44 401 10 32
info@remeda.ch
www.remeda.ch